AKT1 and colorectal cancer: Our previous study [9] in colorectal cancer also demonstrated a higher incidence of mutations in PI3K/AKT pathway genes (PIK3CA, PTEN, and AKT1) in the EMAST+/MSI-H tumors than in other subtypes.